| DRAVPa2301 |
Sequence 3 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2302 |
Sequence 4 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2303 |
Sequence 5 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2304 |
Sequence 6 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2305 |
Sequence 7 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2306 |
Sequence 8 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2307 |
Sequence 9 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2308 |
Sequence 10 from Patent US6337074B1 |
Synthetic peptide |
Herpesviruses |
US6337074B1 |
| DRAVPa2309 |
Sequence 1 from Patent US20210040153A1 |
Synthetic peptide |
DENV |
US20210040153A1 |
| DRAVPa2310 |
Sequence 2 from Patent US20210040153A1 |
Synthetic peptide |
DENV |
US20210040153A1 |
| DRAVPa2311 |
Sequence 2 from Patent CN118451094A |
Synthetic peptide |
SARS-CoV-2 |
CN118451094A |
| DRAVPa2312 |
Sequence 3 from Patent CN118451094A |
Synthetic peptide |
SARS-CoV-2 |
CN118451094A |
| DRAVPa2313 |
Sequence 4 from Patent CN118451094A |
Synthetic peptide |
SARS-CoV-2 |
CN118451094A |
| DRAVPa2314 |
Sequence 1 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2315 |
Sequence 2 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2316 |
Sequence 3 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2317 |
Sequence 4 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2318 |
Sequence 5 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2319 |
Sequence 6 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |
| DRAVPa2320 |
Sequence 7 from Patent CN108409866A |
Synthetic peptide |
HPV |
CN108409866A |